Patent · US Active

Compounds (cystein based lipopeptides) and compositions as TLR2 agonists used for treating infections, inflammations, respiratory diseases etc

US8808703B2 · kind B2 · utility

4Cited by

0References

18Claims

0Family size

Inventors

Tom Yao-Hsiang Wu · San Diego, US
Yefen Zou · San Diego, US
Timothy Z. Hoffman · San Diego, US
Jianfeng PAN · San Diego, US

Key dates

Filing date	Mar 23, 2011
Grant date	Aug 19, 2014
Priority date	—
Expiry date	Aug 24, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C2601/02
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides a novel class of compounds viz. generally lipopeptides like Pam3CSK4, immunogenic compositions and pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with Toll-Like Receptors 2. In one aspect, the compounds are useful as adjuvants for enhancing the effectiveness a vaccine.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.